WebDystrogen Gene Therapies is a life sciences company focused on the development of therapies for rare genetic neurodegenerative disorders. Our currently most advanced therapeutic candidate is for Huntington’s Disease (HD) and has produced a series of highly promising pre-clinical data. WebApr 8, 2024 · About DT-DEC01. DT-DEC01 is a chimeric cell therapy. The advanced therapeutic medicinal product (ATMP) is made using Dystrogen's proprietary cell engineering technology which creates a DEC cell. Clinically, DEC cells have been shown to express CD56 at significantly higher levels than myoblasts from Duchenne patients.
Dystrogen Therapeutics - Overview, News & Competitors
WebNov 5, 2024 · CHICAGO, Nov. 5, 2024 /PRNewswire/ -- Scientists from Dystrogen Therapeutics Corp. published data supporting cardioprotective effects of the Compa... CHICAGO, Nov. 5, 2024 /PRNewswire ... WebDystrogen Therapeutics - Crunchbase Company Profile & Funding Oops! There was a problem! There was an unexpected issue while trying to process your request. Please refresh the page and try again. If the problem persists, please contact support. Refresh fitfanty sportcamp
Dystrogen Therapeutics
WebApr 7, 2024 · Dystrogen Therapeutics is a clinical-stage life sciences company committed to developing therapies for rare genetic diseases. The company was founded based on the pioneering work of Prof. Maria Siemionow, a world-renowned scientist and surgeon who led the team that performed the first near-total face transplantation in the United States . WebFeb 10, 2024 · Dystrogen Gene Therapies Inc. Dystrogen Gene Therapies is a life sciences company focused on the development of therapies for rare genetic neurodegenerative disorders. Our currently most advanced therapeutic candidate is for Huntington’s Disease (HD) and has produced a series of highly promising pre-clinical data. WebBecause the pathogenesis of polyQ diseases is associated with the presence of toxic proteins, the most direct therapeutic strategies involve silencing of the specific gene expression with the use of anti- senseoligonucleotides(ASO)andRNAinterference(RNAi),prevent- ing mutant protein … fit fanny pack